Acute upper respiratory infections of multiple and unspecified sites

J10_ACUTEUPPERINFEC

No definition available.

Endpoint definition

FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 J06
Hospital discharge: ICD-9 465
Hospital discharge: ICD-8 465
Cause of death: ICD-10 J06
Cause of death: ICD-9 465
Cause of death: ICD-8 465

2 out of 7 registries used, show all original rules.

42419

diagram downward connector

Check minimum number of events None

42419

diagram downward connector

Include endpoints None

42419

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

40768

diagram downward connector
J10_ACUTEUPPERINFEC

Control definitions

Control exclude J10_UPPERINFEC

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 J00-J06
Name in latin Infectiones acutae respiratoriae superiores locis multis sive non specificatis

Summary Statistics

Key figures

All Female Male
Number of individuals 40768 19096 21672
Unadjusted prevalence (%) 9.90 8.29 11.92
Mean age at first event (years) 35.47 39.41 31.99

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.06 3.28 [2.68, 4.00] 2.4e-31 3474
15 years 0.01 1.49 [1.27, 1.75] 1.4e-6 1030
5 years 0.01 4.13 [3.68, 4.65] <1e-100 1180
1 year 0.00 11.57 [10.18, 13.16] <1e-100 727

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: J10_ACUTEUPPERINFEC – Acute upper respiratory infections of multiple and unspecified sites
GWS hits: 1

Survival analyses between endpoints

Plot

before Acute upper respiratory infections of multiple and unspecified sites
after Acute upper respiratory infections of multiple and unspecified sites

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Acute upper respiratory infections of multiple and unspecified sites

Endpoint not on priority list, no data to show.